Novartis Sponsors "Colors of Hope: Expressions of cancer survivors around the world"
The compelling artwork and stories of fifteen Glivec patients are showcased in a new book created by The Max Foundation to feature entries to their "Patient Art Project".
Darkness, light, family, religion, medicine, hope and gratitude. Many whose lives have been touched by cancer can relate to these themes, which are highlighted in a new book, created by The Max Foundation, that features the artwork and stories of cancer survivors...
UK Sickle Cell Standards
Guidelines strive to maximize quality and consistency of care nationwide.
Millions of people worldwide suffer from Sickle Cell Disease (SCD), an inherited blood disorder that can result in serious complications...
Innovative Partnerships Offer Enhanced Patient Access to Treatment
Novartis Oncology is committed to ensuring access to our medications to patients in need. Our global patient assistance programs have helped more than 30,000 patients gain access to Glivec and now include Tasigna.
Novartis Oncology has a long-held commitment to consistently discovering, developing and making broadly available novel therapies that improve and extend the lives of people with cancer...
